Affordable Access

deepdyve-link
Publisher Website

Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab.

Authors
  • Trinh, Beckey1
  • Donath, Marc Y2, 3
  • Läubli, Heinz3, 4
  • 1 Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland [email protected] , (Switzerland)
  • 2 Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland. , (Switzerland)
  • 3 Department of Biomedicine, University Hospital Basel, Basel, Switzerland. , (Switzerland)
  • 4 Division of Medical Oncology, University Hospital Basel, Basel, Switzerland. , (Switzerland)
Type
Published Article
Journal
Diabetes care
Publication Date
Sep 01, 2019
Volume
42
Issue
9
Identifiers
DOI: 10.2337/dc19-0908
PMID: 31308021
Source
Medline
Language
English
License
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/13/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31308021
Report this publication

Statistics

Seen <100 times